172 related articles for article (PubMed ID: 32007565)
1. Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort.
van de Ven S; van den Bongard D; Pielkenrood B; Kasperts N; Eppinga W; Peters M; Verkooijen H; van der Velden J
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):39-47. PubMed ID: 32007565
[TBL] [Abstract][Full Text] [Related]
2. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer.
Patel PH; Chaw CL; Tree AC; Sharabiani M; van As NJ
World J Urol; 2019 Dec; 37(12):2615-2621. PubMed ID: 31346760
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases.
Pielkenrood BJ; Gal R; Kasperts N; Verhoeff JJC; Bartels MMTJ; Seravalli E; van der Linden YM; Monninkhof EM; Verlaan JJ; van der Velden JM; Verkooijen HM
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1203-1215. PubMed ID: 35017007
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Pain Relief for Bone Metastases: A Systematic Review and Meta-Analysis.
Song X; Wei J; Sun R; Jiang W; Chen Y; Shao Y; Gu W
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):909-921. PubMed ID: 36273520
[TBL] [Abstract][Full Text] [Related]
6. Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.
Nguyen QN; Chun SG; Chow E; Komaki R; Liao Z; Zacharia R; Szeto BK; Welsh JW; Hahn SM; Fuller CD; Moon BS; Bird JE; Satcher R; Lin PP; Jeter M; O'Reilly MS; Lewis VO
JAMA Oncol; 2019 Jun; 5(6):872-878. PubMed ID: 31021390
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
[TBL] [Abstract][Full Text] [Related]
8. A critical appraisal of the four systematic reviews and meta-analysis on stereotactic body radiation therapy versus external beam radiotherapy for painful bone metastases and where we go from here.
Wong HCY; Chan AW; Johnstone P; Simone CB; Navarro-Domenech I; Hoskin P; Johnstone C; Recht A; Menten J; van der Linden YM; van der Velden JM; Nguyen QN; Lutz S; Andratschke N; Wilmann J; Kazmierska J; Spalek M; Lim F; Yu HM; Perez B; Marta GN; Vassiliou V; Lee SF; Bonomo P; Rembielak A; Chow E; Oldenburger E; Raman S
Ann Palliat Med; 2023 Nov; 12(6):1318-1330. PubMed ID: 37303218
[TBL] [Abstract][Full Text] [Related]
9. Re-irradiation for painful bone metastases using stereotactic body radiotherapy.
Ogawa H; Ito K; Shimizuguchi T; Furuya T; Nihei K; Karasawa K
Acta Oncol; 2018 Dec; 57(12):1700-1704. PubMed ID: 30280622
[TBL] [Abstract][Full Text] [Related]
10. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
Muldermans JL; Romak LB; Kwon ED; Park SS; Olivier KR
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):696-702. PubMed ID: 27131082
[TBL] [Abstract][Full Text] [Related]
12. STAT RT: a prospective pilot clinical trial of Scan-Plan-QA-Treat stereotactic body radiation therapy for painful osseous metastases.
Wilson DD; Alonso CE; Sim AJ; Peck T; Handsfield LL; Chen Q; Blackhall L; Showalter TN; Reardon KA; Read PW
Ann Palliat Med; 2019 Jul; 8(3):221-230. PubMed ID: 30691281
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy of bone metastases in oligometastatic disease: prognostic factors of oncologic outcomes.
Ursino S; Montrone S; Cantarella M; Menghini V; Matteucci F; Mazzotti V; Fiorica F; Fedele D; Erba P; Morganti R; Fabrini MG; Caramella D
Tumori; 2016; 102(1):59-64. PubMed ID: 26439149
[TBL] [Abstract][Full Text] [Related]
14. [Stereotactic body radiotherapy (SBRT) for the treatment of bone metastases in oligometastasised prostate cancer].
Sage EK; Vogel MME; Dewes S; Devecka M; Eiber M; Gschwend JE; Combs SE; Schiller K
Aktuelle Urol; 2020 Jun; 51(3):265-270. PubMed ID: 32268437
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
17. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
[TBL] [Abstract][Full Text] [Related]
18. Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer.
Sutera P; Clump DA; Kalash R; D'Ambrosio D; Mihai A; Wang H; Petro DP; Burton SA; Heron DE
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):116-122. PubMed ID: 30149056
[TBL] [Abstract][Full Text] [Related]
19. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
